Author:
Bourque Mélanie,Grégoire Laurent,Di Paolo Thérèse
Funder
Canadian Institute for Health Research (CIHR)
Reference9 articles.
1. Therapies for dopaminergic-induced dyskinesias in Parkinson disease;Gottwald;Ann. Neurol.,2011
2. Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys;Gregoire;Behav. Brain Res.,2015
3. Functions of plasmalogen lipids in health and disease;Braverman;Biochim. Biophys. Acta,2012
4. Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease;Wood;Lipids Health Dis.,2011
5. Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys;Samadi;Ann. Neurol.,2006
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献